BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38742835)

  • 21. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.
    Abunahlah N; Elawaisi A; Velibeyoglu FM; Sancar M
    Int J Clin Pharm; 2018 Apr; 40(2):360-367. PubMed ID: 29380236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
    Umar RM; Apikoglu-Rabus S; Yumuk PF
    Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmaceutical care in a visceral surgical ward].
    Schneider R; Ranft D; Heinitz K; Uhlmann D; Hauss J; Frontini R; Leinung S
    Zentralbl Chir; 2012 Apr; 137(2):173-9. PubMed ID: 21766274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice.
    Sørensen CA; Jeffery L; Falhof J; Harbig P; Roelsgaard K; Gram S; Olesen C
    Ther Adv Drug Saf; 2023; 14():20420986231159221. PubMed ID: 36949765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing.
    Raimbault-Chupin M; Spiesser-Robelet L; Guir V; Annweiler C; Beauchet O; Clerc MA; Moal F
    Int J Clin Pharm; 2013 Oct; 35(5):847-53. PubMed ID: 23857430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determine the impact of a structured pharmacist-led medication review - a controlled intervention study to optimise medication safety for residents in long-term care facilities.
    Lexow M; Wernecke K; Sultzer R; Bertsche T; Schiek S
    BMC Geriatr; 2022 Apr; 22(1):307. PubMed ID: 35397527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge.
    Studer H; Imfeld-Isenegger TL; Beeler PE; Ceppi MG; Rosen C; Bodmer M; Boeni F; Hersberger KE; Lampert ML
    Int J Clin Pharm; 2023 Feb; 45(1):117-125. PubMed ID: 36327045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Clinical Pharmacist-led Approach on Reducing Drug Related Problems Among Patients with Neurological Disorders: An Interventional Study.
    Jimmy N; Upadhya M; Jaison JM; Sidheque S; Sundaramurthy H; Nemichandra SC; Paneyala S; Ramesh M; Sri Harsha C; Syed J; Pal N
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100302. PubMed ID: 37538991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.
    Zaal RJ; Jansen MM; Duisenberg-van Essenberg M; Tijssen CC; Roukema JA; van den Bemt PM
    Int J Clin Pharm; 2013 Oct; 35(5):753-62. PubMed ID: 23715760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identify and categorize drug-related problems in hospitalized surgical patients in China.
    Qu C; Meng L; Wang N; Chen Y; Yang X; Wang J; Sun S; Qiu F
    Int J Clin Pharm; 2019 Feb; 41(1):13-17. PubMed ID: 30610549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the potential impact of resolving drug-related problems by clinical pharmacists in Japan: a retrospective observational study.
    Oki T; Ishii S; Furukawa K; Shono A; Akazawa M
    J Pharm Health Care Sci; 2021 Dec; 7(1):47. PubMed ID: 34865656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study.
    Pehlivanli A; Eyupoglu S; Basgut B; Erturk S; Ozcelikay AT
    BMC Nephrol; 2023 May; 24(1):149. PubMed ID: 37237342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners.
    Nishtala PS; McLachlan AJ; Bell JS; Chen TF
    J Eval Clin Pract; 2011 Feb; 17(1):97-103. PubMed ID: 20825538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia.
    Sagita VA; Bahtiar A; Andrajati R
    Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e81-e87. PubMed ID: 29666686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical care research and education project: pharmacists' interventions.
    Kassam R; Farris KB; Burback L; Volume CI; Cox CE; Cave A
    J Am Pharm Assoc (Wash); 2001; 41(3):401-10. PubMed ID: 11372905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Pharmacist Interventions in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital.
    Al-Quteimat O; Siddiqui M; Hussein L; Al Emleh H; Shamieh IED
    J Pharm Pract; 2023 Jun; 36(3):572-578. PubMed ID: 35001748
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysis.
    Zhai XB; Gu ZC; Liu XY
    Ther Clin Risk Manag; 2016; 12():241-50. PubMed ID: 26937196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-related problems in geriatric rehabilitation patients after discharge - A prevalence analysis and clinical case scenario-based pilot study.
    Freyer J; Hueter L; Kasprick L; Frese T; Sultzer R; Schiek S; Bertsche T
    Res Social Adm Pharm; 2018 Jul; 14(7):628-637. PubMed ID: 28756965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of drug-related problems in the hematology service: a prospective interventional study.
    Albayrak A; Özbalcı D
    BMC Cancer; 2024 May; 24(1):552. PubMed ID: 38698336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol.
    Amador-Fernández N; Escaith M; Simi E; Quintana-Bárcena P; Berger J
    PLoS One; 2023; 18(10):e0292037. PubMed ID: 37847695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.